BACKGROUND: The genetic characterization of wild-type measles viruses plays an important role in the description of viral transmission pathways and the verification of measles elimination. The 450 nucleotides that encode the carboxyl-terminus of the nucleoprotein (N-450) are routinely sequenced for genotype analysis. OBJECTIVES: The objectives of this study were to develop improved primers and controls for RT-PCR reactions used for genotyping of measles samples and to develop a method to provide a convenient, safe, and inexpensive means to distribute measles RNA for RT-PCR assays and practice panels. STUDY DESIGN: A newly designed, genetically defined synthetic RNA and RNA isolated from cells infected with currently circulating genotypes were used to compare the sensitivity of primer pairs in RT-PCR and nested PCR. FTA® cards loaded with lysates of measles infected cells were tested for their ability to preserve viral RNA and destroy virus infectivity. RESULTS: A new primer pair, MeV216/MeV214, was able to amplify N-450 from viruses representing 10 currently circulating genotypes and a genotype A vaccine strain and demonstrated 100-fold increased sensitivity compared to the previously used primer set. A nested PCR assay further increased the sensitivity of detection from patient samples. A synthetic positive control RNA was developed that produced PCR products that are distinguishable by size from PCR products amplified from clinical samples. FTA® cards completely inactivated measles virus and stabilized RNA for at least six months. CONCLUSIONS: These improved molecular tools will advance molecular characterization of circulating measles viruses globally and provide enhanced quality control measures. Published by Elsevier B.V.
BACKGROUND: The genetic characterization of wild-type measles viruses plays an important role in the description of viral transmission pathways and the verification of measles elimination. The 450 nucleotides that encode the carboxyl-terminus of the nucleoprotein (N-450) are routinely sequenced for genotype analysis. OBJECTIVES: The objectives of this study were to develop improved primers and controls for RT-PCR reactions used for genotyping of measles samples and to develop a method to provide a convenient, safe, and inexpensive means to distribute measles RNA for RT-PCR assays and practice panels. STUDY DESIGN: A newly designed, genetically defined synthetic RNA and RNA isolated from cells infected with currently circulating genotypes were used to compare the sensitivity of primer pairs in RT-PCR and nested PCR. FTA® cards loaded with lysates of measles infected cells were tested for their ability to preserve viral RNA and destroy virus infectivity. RESULTS: A new primer pair, MeV216/MeV214, was able to amplify N-450 from viruses representing 10 currently circulating genotypes and a genotype A vaccine strain and demonstrated 100-fold increased sensitivity compared to the previously used primer set. A nested PCR assay further increased the sensitivity of detection from patient samples. A synthetic positive control RNA was developed that produced PCR products that are distinguishable by size from PCR products amplified from clinical samples. FTA® cards completely inactivated measles virus and stabilized RNA for at least six months. CONCLUSIONS: These improved molecular tools will advance molecular characterization of circulating measles viruses globally and provide enhanced quality control measures. Published by Elsevier B.V.
Entities:
Keywords:
CDC; Centers for Disease Control and Prevention; Ct; FTA(®) cards; Genotyping; LabNet; MeV; Measles; Molecular diagnostics; RT; WHO; WHO Measles and Rubella Laboratory Network; World Health Organization; cpe; cytopathic effect; measles virus; nt; nucleotides; room temperature; threshold cycle
Authors: Gibson K S Woo; Ann H Wong; W Y Lee; C S Lau; Peter K C Cheng; Peter C K Leung; Wilina W L Lim Journal: J Med Virol Date: 2010-10 Impact factor: 2.327
Authors: Apollo Muwonge; Miriam Nanyunja; Paul A Rota; Josephine Bwogi; Luis Lowe; Stephanie L Liffick; William J Bellini; Sempala Sylvester Journal: Emerg Infect Dis Date: 2005-10 Impact factor: 6.883
Authors: Bettina Bankamp; Carolyn Sein; Elisabeth Pukuta Simbu; Raydel Anderson; Emily Abernathy; Min-Hsin Chen; Jean-Jacques Muyembe Tamfum; Kathleen A Wannemuehler; Diane Waku-Kouomou; Elena N Lopareva; Joseph P Icenogle; Paul A Rota; James L Goodson Journal: J Clin Microbiol Date: 2019-04-26 Impact factor: 5.948
Authors: Kimberley S M Benschop; Harrie G van der Avoort; Edin Jusic; Harry Vennema; Rob van Binnendijk; Erwin Duizer Journal: Appl Environ Microbiol Date: 2017-06-16 Impact factor: 4.792
Authors: P K Ndombo; V N Ndze; F D Mbarga; R Anderson; A Acho; J Ebua Chia; A K Njamnshi; P A Rota; D Waku-Kouomou Journal: Epidemiol Infect Date: 2018-01-09 Impact factor: 4.434
Authors: Amy Parker Fiebelkorn; Susan B Redd; Paul A Gastañaduy; Nakia Clemmons; Paul A Rota; Jennifer S Rota; William J Bellini; Gregory S Wallace Journal: J Pediatric Infect Dis Soc Date: 2017-03-01 Impact factor: 3.164